Nom du produit:5-Oxazolecarboxylic acid, 2-cyclopropyl-

IUPAC Name:2-cyclopropyl-1,3-oxazole-5-carboxylic acid

CAS:1263378-39-7
Formule moléculaire:C7H7NO3
Pureté:95%+
Numéro de catalogue:CM464153
Poids moléculaire:153.14

Unité d'emballage Stock disponible Prix($) Quantité
CM464153-100mg in stock ƥƥƿ
CM464153-250mg in stock ƥȺƥ
CM464153-1g in stock ȡƥȐ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1263378-39-7
Formule moléculaire:C7H7NO3
Point de fusion:-
Code SMILES:OC(=O)C1=CN=C(O1)C1CC1
Densité:
Numéro de catalogue:CM464153
Poids moléculaire:153.14
Point d'ébullition:
N° Mdl:MFCD18432565
Stockage:

Category Infos

Oxazoles
Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.